Inhibition of poly(ADP-ribose) glycohydrolase (PARG) specifically kills BRCA2-deficient tumor cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cell Cycle

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.11.5.19482PMID 22333589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PARP-3 and APLF function together to accelerate nonhomologous end-joining.

  2011cited by this paper
• The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase

  2011cited by this paper
• Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations

  2011cited by this paper
• Discovery and structure-activity relationships of modified salicylanilides as cell permeable inhibitors of poly(ADP-ribose) glycohydrolase (PARG).

  2011cited by this paper
• Gallotannin inhibits NFĸB signaling and growth of human colon cancer xenografts

  2011cited by this paper
• Pathways of mammalian replication fork restart

  2010cited by this paper
• Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate

  2010cited by this paper
• Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis.

  2010cited by this paper
• AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers

  2010cited by this paper
• Molecular and Cellular Pathobiology Cancer Research Poly ( ADP-Ribose ) Polymerase Is Hyperactivated in Homologous Recombination – Defective Cells

  2010cited by this paper
• Expressions of poly (ADP-ribose) glycohydrolase (PARG) and membrane type 1 matrix metalloproteinase (MT1-MMP) in colorectal carcinoma

  2010cited by this paper
• Relationship of PARG with PARP, VEGF and b-FGF in colorectal carcinoma

  2009cited by this paper
• Dual role of poly(ADP‐ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells

  2009cited by this paper
• PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombination

  2009cited by this paper
• Radiation-induced mitotic catastrophe in PARG-deficient cells

  2009cited by this paper
• PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA

  2008cited by this paper
• AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51.

  2008cited by this paper
• APLF (C2orf13) Is a Novel Component of Poly(ADP-Ribose) Signaling in Mammalian Cells

  2008cited by this paper
• Mono‐galloyl glucose derivatives are potent poly(ADP‐ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP‐1‐dependent cell death

  2008cited by this paper
• Poly(ADP-Ribose) Polymerase 1 Accelerates Single-Strand Break Repair in Concert with Poly(ADP-Ribose) Glycohydrolase

  2007cited by this paper
• Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair

  2006cited by this paper
• DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.

  2006cited by this paper
• Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.

  2006cited by this paper
• Poly(ADP-ribose): novel functions for an old molecule

  2006cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Spontaneous Homologous Recombination Is Induced by Collapsed Replication Forks That Are Caused by Endogenous DNA Single-Strand Breaks

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005influential reference
• Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide.

  2005cited by this paper
• Involvement of Poly(ADP-ribose) Polymerase-1 and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks Rejoining*

  2004cited by this paper
• Depletion of the 110-Kilodalton Isoform of Poly(ADP-Ribose) Glycohydrolase Increases Sensitivity to Genotoxic and Endotoxic Stress in Mice

  2004cited by this paper
• Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks

  2004cited by this paper
• Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality.

  2004cited by this paper
• Poly(ADP-ribose) Polymerase-1 (PARP-1) Is Required in Murine Cell Lines for Base Excision Repair of Oxidative DNA Damage in the Absence of DNA Polymerase β*

  2003cited by this paper
• A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage.

  2003cited by this paper
• Spatial and Temporal Cellular Responses to Single-Strand Breaks in Human Cells

  2003cited by this paper
• Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage

  2002cited by this paper
• AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells.

  2001cited by this paper
• Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage.

  1999cited by this paper
• DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines.

  1998cited by this paper
• A partial hprt gene duplication generated by non-homologous recombination in V79 Chinese hamster cells is eliminated by homologous recombination.

  1998cited by this paper
• Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis

  1997cited by this paper
• Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro.

  1996cited by this paper
• Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks.

  1995cited by this paper
• Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes.

  1995cited by this paper
• Endoglycosidic cleavage of branched polymers by poly(ADP-ribose) glycohydrolase.

  1994cited by this paper
• Mode of action of poly(ADP-ribose) glycohydrolase.

  1994cited by this paper
• Depletion of poly(ADP-ribose) polymerase by antisense RNA expression results in a delay in DNA strand break rejoining.

  1992cited by this paper
• Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks.

  1980cited by this paper
• Purification and properties of glycohydrolase from calf thymus splitting ribose-ribose linkages of poly(adenosine diphosphate ribose).

  1974cited by this paper

• The PARG frontier: mechanisms of PAR turnover and opportunities in precision oncology.

  2026cites this paper
• Targeting dePARylation in cancer therapy.

  2025cites this paper
• Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis

  2025cites this paper
• Drugging the DNA damage response in the clinic: going beyond PARP

  2025cites this paper
• Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directions.

  2025cites this paper
• Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic Opportunities

  2025influential citation
• Targeting DNA Damage Repair Pathways Beyond PARP Inhibition

  2025influential citation
• DePARylation is critical for S phase progression and cell survival

  2024cites this paper
• An update on small molecule compounds targeting synthetic lethality for cancer therapy.

  2024cites this paper
• New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives

  2024cites this paper
• Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity.

  2024cites this paper
• Targeting OGG1 and PARG radiosensitises head and neck cancer cells to high-LET protons through complex DNA damage persistence

  2024cites this paper
• ADP-ribose hydrolases: biological functions and potential therapeutic targets

  2024cites this paper
• PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance.

  2023cites this paper
• DePARylation is critical for S phase progression and cell survival

  2023cites this paper
• DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy

  2023cites this paper
• Sulfoquinovosyl acylpropanediol (SQAP): Inhibition of poly(ADP-ribose) metabolism and enhanced cytotoxicity in homologous recombination repair-deficient Chinese hamster-derived cells.

  2023cites this paper
• Theranostic Interpolation of Genomic Instability in Breast Cancer

  2022cites this paper
• Genomic and biological aspects of resistance to selective poly(ADP‐ribose) glycohydrolase inhibitor PDD00017273 in human colorectal cancer cells

  2022cites this paper
• Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers

  2021cites this paper
• Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents

  2021cites this paper
• Progress in reversible ADP- ribosylation modification in DNA damage repair and cancer treatment

  2021cites this paper
• Poly(ADP-Ribosyl) Code Functions

  2021cites this paper
• PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair

  2021cites this paper
• Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers

  2021cites this paper
• DNA replication stress and emerging prospects for PARG inhibitors in ovarian cancer therapy.

  2021cites this paper
• Targeting DNA repair pathway in cancer: Mechanisms and clinical application

  2021cites this paper
• Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy

  2020cites this paper
• PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.

  2020cites this paper
• Role of Akt Activation in PARP Inhibitor Resistance in Cancer

  2020cites this paper
• Base excision repair and its implications to cancer therapy

  2020cites this paper
• Targeting dePARylation for cancer therapy

  2020cites this paper
• PARP and PARG inhibitors in cancer treatment.

  2020influential citation
• Mitotic functions of poly(ADP-ribose) polymerases

  2019cites this paper
• PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.

  2019cites this paper
• Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy.

  2019cites this paper
• Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer.

  2019cites this paper
• Dysfunction of poly(ADP-ribose) glycohydrolase induces a synthetic lethal effect in dual specificity phosphatase 22-deficient lung cancer cells.

  2019cites this paper
• DNA Double Strand Break Repair - Related Synthetic Lethality.

  2019cites this paper
• Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death

  2019cites this paper
• Multiple Roles for Mono- and Poly(ADP-Ribose) in Regulating Stress Responses.

  2019cites this paper
• The role of dePARylation in DNA damage repair and cancer suppression.

  2019cites this paper
• Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation

  2019cites this paper
• Comprehensive analysis of telomerase inhibition by gallotannin

  2018influential citation
• Specificity of reversible ADP-ribosylation and regulation of cellular processes

  2018cites this paper
• Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.

  2018cites this paper
• Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity

  2018cites this paper
• Molecular strategies to reduce unnecessary repeat prostate biopsies of men with elevated serum PSA

  2018cites this paper
• Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib

  2018influential citation
• Poly-ADP ribosylation in DNA damage response and cancer therapy.

  2017cites this paper
• Purification of Recombinant Human PARP-3.

  2017cites this paper
• DNA damage repair in breast cancer and its therapeutic implications.

  2017cites this paper
• Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase

  2017cites this paper
• Targeting DNA Repair in Cancer: Beyond PARP Inhibitors.

  2017cites this paper
• PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency

  2016influential citation
• Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation

  2016cites this paper
• PARG Inhibitors and Functional PARG Inhibition Models.

  2016cites this paper
• Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.

  2016cites this paper
• Poly(ADP-ribose): From chemical synthesis to drug design.

  2016cites this paper
• Functional relevance of the candidate genes MSMB , NCOA 4 , TIMM 23 and PARG in the prostate cancer risk region 10 q 11 for the emergence of oncogenic TMPRSS 2 : ERG fusions

  2016cites this paper
• First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib.

  2016cites this paper
• Macrodomains: Structure, Function, Evolution, and Catalytic Activities.

  2016cites this paper
• A Selective Small Molecule DNA2 Inhibitor for Sensitization of Human Cancer Cells to Chemotherapy

  2016cites this paper
• Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics.

  2015cites this paper
• New paradigms in the repair of oxidative damage in human genome: mechanisms ensuring repair of mutagenic base lesions during replication and involvement of accessory proteins

  2015cites this paper
• The rise and fall of poly(ADP-ribose): An enzymatic perspective.

  2015cites this paper
• Role of Poly ADP-Ribose Polymerase (PARP) Inhibitors in Triple-Negative Breast Cancer (TNBC)

  2015cites this paper
• PARG is dispensable for recovery from transient replicative stress but required to prevent detrimental accumulation of poly(ADP-ribose) upon prolonged replicative stress

  2014cites this paper
• Gallotannin Imposes S Phase Arrest in Breast Cancer Cells and Suppresses the Growth of Triple-Negative Tumors In Vivo

  2014cites this paper
• The Distinctive Properties of Parp and Parg as a Cancer Therapeutic Target

  2014cites this paper
• A Quantitative Assay Reveals Ligand Specificity of the DNA Scaffold Repair Protein XRCC1 and Efficient Disassembly of Complexes of XRCC1 and the Poly(ADP-ribose) Polymerase 1 by Poly(ADP-ribose) Glycohydrolase*

  2014cites this paper
• Poly(ADP-Ribosyl) Glycohydrolase Prevents the Accumulation of Unusual Replication Structures during Unperturbed S Phase

  2014cites this paper
• The oligonucleotide/oligosaccharide-binding fold motif is a poly(ADP-ribose)-binding domain that mediates DNA damage response

  2014cites this paper
• Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.

  2013cites this paper
• Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis.

  2013cites this paper
• The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response

  2013cites this paper
• The recognition and removal of cellular poly(ADP‐ribose) signals

  2013cites this paper
• Host Cell Poly(ADP-Ribose) Glycohydrolase Is Crucial for Trypanosoma cruzi Infection Cycle

  2013cites this paper
• A role of intracellular mono‐ADP‐ribosylation in cancer biology

  2013cites this paper
• Poly(ADP-ribose): PARadigms and PARadoxes.

  2013cites this paper
• Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP-ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells

  2012cites this paper
• ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6.

  2012cites this paper
• The Sound of Silence: RNAi in Poly (ADP-Ribose) Research

  2012cites this paper
• Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives

  2012cites this paper
• Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?

  2012cites this paper
• Molecular Insights into Poly(ADP-ribose) Recognition and Processing

  2012cites this paper
• Tankyrase-targeted therapeutics: expanding opportunities in the PARP family

  2012cites this paper